DRKS00003932CompletedNot Applicable
Association of multiple myeloma (MM) with different neoplasms (DN), including second primary malignancies (SPM): systematic analysis in consecutive patients
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- niversitätsklinikum Freiburg
- Enrollment
- 744
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to one (—)
- Sex
- All
Inclusion Criteria
- •Patients with mulrtiple myeloma
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Active, not recruiting
Phase 4
STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMAMultiple MyelomaNCT03829371University of Turin, Italy450
Not yet recruiting
Not Applicable
Clinical Profile Of Multiple MyelomaCTRI/2021/08/035576Kasturba Medical College
Completed
Not Applicable
High Dose Therapy Followed by Autologous Transplantation for Myeloma Patients With Severe Renal ImpairmentMultiple MyelomaRenal FailureNCT03234335Centre Hospitalier Universitaire de Saint Etienne50
Active, not recruiting
Not Applicable
Randomised comparisons, in myeloma patients of all ages, of thalidomide, lenalidomide, carfilzomib and bortezomib induction combinations, and of lenalidomide and combination lenalidomide vorinostat as maintenance - Myeloma XIewly diagnosed patients with symptomatic myelomaMedDRA version: 16.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864EUCTR2009-010956-93-GBniversity of Leeds4,000
Unknown
Not Applicable
A Head-to-head Comparative Study of 18F-PSMA-1007 PET/CT and 18F-FDG PET/CT Imaging in Multiple MyelomaMultiple MyelomaNCT05448404First Hospital of China Medical University30